Cargando…
CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance
Radiotherapy is a mainstay for treatment of many human cancer types, including head and neck squamous cell carcinoma (HNSCC). Thereby, it is clinically very relevant to understand the mechanisms determining radioresistance. Here, we identify CIP2A as an Oct4 target gene and provide evidence that the...
Autores principales: | Ventelä, Sami, Sittig, Eleonora, Mannermaa, Leni, Mäkelä, Juho-Antti, Kulmala, Jarmo, Löyttyniemi, Eliisa, Strauss, Leena, Cárpen, Olli, Toppari, Jorma, Grénman, Reidar, Westermarck, Jukka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381584/ https://www.ncbi.nlm.nih.gov/pubmed/25474139 |
Ejemplares similares
-
CIP2A Promotes Proliferation of Spermatogonial Progenitor Cells and Spermatogenesis in Mice
por: Ventelä, Sami, et al.
Publicado: (2012) -
MYC is not detected in highly proliferating normal spermatogonia but is coupled with CIP2A in testicular cancers
por: Ventelä, Sami, et al.
Publicado: (2016) -
Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma
por: Routila, Johannes, et al.
Publicado: (2021) -
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia
por: Mäkelä, Eleonora, et al.
Publicado: (2019) -
Reconstruction of Mouse Testicular Cellular Microenvironments in Long-Term Seminiferous Tubule Culture
por: Mäkelä, Juho-Antti, et al.
Publicado: (2014)